SELECTIVE DELETION OF NEUTROPHIL NADPH OXIDASE AND INNATE RESPONSES TO ASPERGILLUS FUMIGATUS
中性粒细胞 NADPH 氧化酶的选择性缺失和对烟曲霉的先天反应
基本信息
- 批准号:9368526
- 负责人:
- 金额:$ 38.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-09 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:AbscessAddressAffectAlveolarAlveolar MacrophagesAntifungal AgentsAspergillosisAspergillusAspergillus fumigatusAttenuatedBacterial InfectionsBreathingCell WallCellsChemotactic FactorsChronic Granulomatous DiseaseComplicationDataDiseaseDoseEnzymesExhibitsFailureGene TargetingGeneticGenetically Engineered MouseGoalsGranulomatousHeritabilityHourHumanHyphaeImmuneImmune responseImmunityImmunologic Deficiency SyndromesImpairmentIn VitroInfectionInfiltrationInflammationInflammation MediatorsInflammatoryInflammatory ResponseInheritedKnockout MiceLeukocytesLifeLungMediatingMediator of activation proteinMoldsMolecularMusMutationMycosesMyeloid CellsNADPH OxidaseNatural ImmunityOpportunistic InfectionsOxidantsOxidasesPathway interactionsPatientsPatternPhagocytesPharmaceutical PreparationsPhenotypePlayPneumoniaProductionReactive Oxygen SpeciesRecurrenceReportingReproduction sporesResidual stateResistanceRiskRoleS100A8 geneSourceSterilitySurfaceTransgenesTransgenic OrganismsWild Type MouseWorkchemotherapycytokineimprovedin vivoinsightkillingsmacrophagemicrobicidemonocytemouse modelneutrophilnovelnovel therapeutic interventionpathogenpatient populationpreventreceptorresponserestorationsuperoxide-generating NADPH oxidasetranslational impact
项目摘要
Summary
Pneumonia resulting from inhaling spores of the opportunistic mold Aspergillus fumigatus (AF) remains a life-
threatening complication of chronic granulomatous disease (CGD) and other conditions with compromised
innate antifungal immunity. CGD is a heritable immunodeficiency arising from inactivating mutations in the
phagocyte NADPH oxidase that generates superoxide (O2-).1, 2 Lack of microbicidal O2--derived reactive
oxygen species (ROS) leads to recurrent bacterial and fungal infections. CGD patients are also prone to
excessive and detrimental inflammation. Aspergillus pneumonia in CGD is associated with pyogranulomatous
inflammation that complicates treatment. After conidia are inhaled, host receptors for fungal pathogen-
associated molecular patterns (PAMPs) trigger inflammatory mediator production and activate killing by
macrophages, neutrophils (polymorphonuclear leukocytes, PMN) and other leukocytes, which rapidly
eliminates AF from normal hosts. Failure to do so results in AF pneumonia. Although patients with CGD and
mice genetically engineered with similar mutations (CGD mice) are among the most susceptible, our
understanding of how NADPH oxidase ROS control AF and its associated inflammation in the lung are ill-
defined. To address this question, we developed new mouse models in which the NADPH oxidase is
selectively deleted in PMN or resident lung alveolar macrophages (AM). Our preliminary data show that mice
lacking only PMN NADPH oxidase ROS exhibited a phenotype similar to CGD mice, and were susceptible to
both AF pneumonia and hyperinflammation following challenge with sterile fungal cell walls, despite intact
NADPH oxidase activity in other cells. In contrast, mice lacking NADPH oxidase in AM, but with residual
oxidase activity in most PMN and monocytes, resembled WT mice in these studies. We propose to determine
how the PMN NADPH oxidase is crucial in the early innate responses to AF, including an unexplained role in
regulating fungal PAMP-induced inflammation. In Aim 1, we will assess whether PMN ROS play a non-
redundant role in the initial response to AF that is critical to prevent lung infection, although it is possible that
other sources of oxidase ROS or non-oxidative mechanisms could suffice at low inocula. In Aim 2, we will
determine how PMN NADPH oxidase regulates fungal PAMP-induced inflammation. We hypothesize that lack
of PMN ROS leads to excessive release inflammatory cytokines, including PMN chemoattractants produced by
PMN themselves. We will examine the response of oxidase-deficient PMN to sterile fungal PAMPs both in vitro
and in the lung to determine how loss of PMN ROS exacerbates inflammation independent of active infection.
We will investigate the impact of blocking specific inflammatory mediators after fungal cell wall challenge. If
effective, we will evaluate this approach in CGD mice as a means to reduce excessive inflammation and
improve control of AF. The proposed studies will provide novel insights into incompletely characterized factors
that contribute to life-threatening infection with AF and guide new therapeutic strategies.
总结
由吸入机会性霉菌烟曲霉(AF)孢子引起的肺炎仍然是一种生命-
慢性肉芽肿病(CGD)和其他疾病的威胁并发症,
先天抗真菌免疫CGD是一种遗传性免疫缺陷,由免疫缺陷细胞中的失活突变引起。
吞噬细胞NADPH氧化酶,产生超氧化物(O2-)。1,2缺乏杀微生物O2-衍生反应
氧物种(ROS)导致反复的细菌和真菌感染。CGD患者也容易出现
过度和有害的炎症。CGD中的曲霉菌肺炎与脓肉芽肿相关
使治疗复杂化的炎症。分生孢子被吸入后,真菌病原体的宿主受体-
相关分子模式(PAMPs)触发炎症介质的产生并激活杀伤,
巨噬细胞、中性粒细胞(多形核白细胞,PMN)和其他白细胞,
消除正常主机的AF。否则会导致AF肺炎。尽管CGD患者和
具有类似突变的基因工程小鼠(CGD小鼠)是最易感的,我们
了解NADPH氧化酶ROS如何控制AF及其相关的肺部炎症,
定义了为了解决这个问题,我们开发了新的小鼠模型,其中NADPH氧化酶是
在PMN或肺泡巨噬细胞(AM)中选择性缺失。我们的初步数据显示,
仅缺乏PMN NADPH氧化酶的ROS表现出与CGD小鼠相似的表型,并且对
无菌真菌细胞壁激发后的AF肺炎和炎症过度,尽管完整
其他细胞中的NADPH氧化酶活性。相反,AM中缺乏NADPH氧化酶的小鼠,
在这些研究中,大多数PMN和单核细胞的氧化酶活性与WT小鼠相似。我们建议确定
PMN NADPH氧化酶如何在AF的早期先天反应中起关键作用,包括在
调节真菌PAMP诱导的炎症。在目标1中,我们将评估PMN ROS是否发挥非-
在对AF的初始反应中起着多余的作用,这对预防肺部感染至关重要,尽管有可能
其它来源的氧化酶ROS或非氧化机制在低接种量下可能足够。在目标2中,我们将
确定PMN NADPH氧化酶如何调节真菌PAMP诱导的炎症。我们假设缺乏
PMN ROS的过度释放导致炎性细胞因子的过度释放,
PMN自己我们将在体外研究氧化酶缺陷型PMN对无菌真菌PAMPs的反应,
以及在肺中,以确定中性粒细胞活性氧的丧失如何独立于活动性感染而加重炎症。
我们将研究真菌细胞壁攻击后阻断特定炎症介质的影响。如果
有效,我们将在CGD小鼠中评估这种方法作为减少过度炎症的手段,
改善AF的控制。拟议的研究将提供新的见解不完全特征的因素
这有助于威胁生命的房颤感染,并指导新的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mary C Dinauer其他文献
Mary C Dinauer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mary C Dinauer', 18)}}的其他基金
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
X连锁慢性肉芽肿性疾病的基因治疗
- 批准号:
7458723 - 财政年份:2007
- 资助金额:
$ 38.13万 - 项目类别:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
X连锁慢性肉芽肿性疾病的基因治疗
- 批准号:
7440956 - 财政年份:2006
- 资助金额:
$ 38.13万 - 项目类别:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
X连锁慢性肉芽肿性疾病的基因治疗
- 批准号:
7089588 - 财政年份:2005
- 资助金额:
$ 38.13万 - 项目类别:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
X连锁慢性肉芽肿性疾病的基因治疗
- 批准号:
6879596 - 财政年份:2004
- 资助金额:
$ 38.13万 - 项目类别:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
X连锁慢性肉芽肿性疾病的基因治疗
- 批准号:
6105676 - 财政年份:1998
- 资助金额:
$ 38.13万 - 项目类别:
GENE THERAPY OF X-LINKED CHRONIC GRANULOMATOUS DISEASE
X连锁慢性肉芽肿性疾病的基因治疗
- 批准号:
6110406 - 财政年份:1998
- 资助金额:
$ 38.13万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 38.13万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 38.13万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 38.13万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 38.13万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 38.13万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 38.13万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 38.13万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 38.13万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 38.13万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 38.13万 - 项目类别:
Research Grant